What is Zacks Research’s Estimate for BMRN Q3 Earnings?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research raised their Q3 2025 earnings estimates for BioMarin Pharmaceutical in a report released on Monday, February 17th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.73 per share for the quarter, up from their previous estimate of $0.72. The consensus […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research raised their Q3 2025 earnings estimates for BioMarin Pharmaceutical in a report released on Monday, February 17th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.73 per share for the quarter, up from their previous estimate of $0.72. The consensus […]
